Cargando…
Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy
Colorectal patients generally have the maximum counts of Fusobacterium nucleatum (F. nucleatum) in tumors and elevate colorectal adenomas and carcinomas, which show the lowest rate of human survival. Hence, F. nucleatum is a diagnostic marker of colorectal cancer (CRC). Studies demonstrated that tar...
Autores principales: | Ganesan, Kumar, Guo, Songhe, Fayyaz, Sundaz, Zhang, Ge, Xu, Baojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827134/ https://www.ncbi.nlm.nih.gov/pubmed/31635333 http://dx.doi.org/10.3390/cancers11101592 |
Ejemplares similares
-
Fusobacterium nucleatum and Colorectal Cancer
por: Li, Rongrong, et al.
Publicado: (2022) -
Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer
por: Guevarra, Leonardo A., et al.
Publicado: (2018) -
Fusobacterium nucleatum-positive colorectal cancer
por: Yang, Zhenhua, et al.
Publicado: (2019) -
Fn-Dps, a novel virulence factor of Fusobacterium nucleatum, disrupts erythrocytes and promotes metastasis in colorectal cancer
por: Wu, Yixian, et al.
Publicado: (2023) -
Fusobacterium nucleatum and cancer
por: Alon‐Maimon, Tamar, et al.
Publicado: (2022)